bexobrutideg
Asset
Targeted protein degrader (PROTAC) targeting Bruton tyrosine kinase (BTK).
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Proteostasis
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Chronic lymphocytic leukemia
Phase 1, globenewswire.com, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets2
- Competitors6
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 1 source